Floatz logo

Abiraterone Acetate

MRD

M.D. Anderson Cancer CenterActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the MRD cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
The First Affiliated Hospital of Soochow University
Phase 4BB
DARATUMUMAB
The First Affiliated Hospital of Soochow University
Phase 4BB
cc-5013
The First Affiliated Hospital of Soochow University
Phase 4BB
DEXAMETHASONE
The First Affiliated Hospital of Soochow University
Phase 4BB
Carfilzomib
The First Affiliated Hospital of Soochow University
Phase 4BB

View all 15 →

Same molecule, other indications

Abiraterone Acetate is also rated in:

prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Metastatic Castration Resistant Prostate CancerDormant
BBB
Indicative ·
72 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →